Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of hepatitis B antiviral therapy on bone health
RBR-6f4x7pCompleted
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tenofovir, entecavir and lamivudine in Chronic Hepatitis B (CHB) (3 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoint: Bone mineral density. Started Sep 2016; status: completed.
02
Drugs
tenofovirentecavirlamivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on RBR-6f4x7p.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6f4x7p.